Uveitis Treatment Market: Current Analysis and Forecast (2021-2027)
$3999 – $6999
Emphasis By Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy & Targeted Therapies, Others); Diseases Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis); By End-User (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online pharmacies); and Region/Country.
Detailed Analysis of COVID-19 Impact on the Uveitis Treatment Market
The uveitis treatment market is expected to witness a CAGR of around 6% during the forecast period (2021–2027). Uveitis (chorioretinitis) is an inflammation of the middle layer of the eye for this complication the most common type is an inflammation of the iris called iritis (anterior uveitis). The major symptoms include redness, pain, light sensitivity, blurred vision, and dark floating spots in the field of vision. The common treatment for uveitis is eye drops, antibiotics or antiviral medication may be prescribed. As per WHO, lifestyle changes and urbanization will also dramatically increase the number of people with eye conditions, vision impairment, and blindness in the coming decades. For instance, On the basis of a study on medical records from California communities, uveitis leads to 30,000 new cases of blindness each year contributing to nearly 10% of all the blind cases.
AbbVie Inc., Alimera Sciences Inc., Allergan Plc., Amgen Inc., Bausch Health Companies Inc., Clearside Biomedical Inc., EyePoint Pharmaceuticals Inc., Mylan N.V., Novartis AG, Santen Pharmaceutical Co. Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with the new and advanced uveitis treatment.
Insights Presented in the Report
“Amongst Drug Class, the anti-inflammatory category accounted for the majority share in the market in 2020”
Based on drug class, the uveitis treatment market is segmented into anti-inflammatory, antimicrobial drugs, immunotherapy & targeted therapies, and others. The anti-inflammatory category is anticipated to witness a significant growth rate during the forecast period. Anti-inflammatory medicines are used in the eyes to reduce problems that can occur during or after eye surgeries or treatment. Furthermore, this is mainly due to rising cases of cataracts, glaucoma, band keratopathy, autoimmune and inflammatory illnesses, etc. these factors are driving the growth of the uveitis treatment market during the forecast period. For instance, The Food and Drug Administration (FDA) has approved YUTIQ (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious uveitis.
“Amongst Diseases Type, the anterior uveitis category accounted for the majority share in the market in 2020”
Based on disease type, the uveitis treatment market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis, and pan uveitis. The anterior uveitis category is anticipated to witness a significant growth rate during the forecast period. Moreover, posterior uveitis is expected to witness lucrative growth during the study period owing to the availability of various drugs. Furthermore, the prevalence of the growth of this segment is mainly due to rising eye diseases such as glaucoma, retinal edema, autoimmune or inflammatory disease, decreased vision, etc. For instance, according to an article published by the Ocular Immunology and Uveitis Foundation in April 2022, uveitis afflicts 109,000 people in the U.S. and 43,000 new cases are diagnosed.
“Amongst Distribution Channel, the hospital pharmacies category is expected to witness the highest CAGR during the forecast period”
Based on distribution channel, the uveitis treatment market is categorized into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies category is anticipated to witness a significant growth rate during the forecast period. This category is especially driven by the higher number of patients with eye-related complications and the availability of healthcare professionals in hospitals. However, the online pharmacy segment is expected to witness significant CAGR owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy. Furthermore, the growing focus on digitization and rising internet penetration in developing are some other key factors driving the category’s growth.
“North America to witness significant growth during the forecast period”
For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Rest of Asia-Pacific) and Rest of World. In 2020, North America accounted for a considerable market share. This is mainly due to the rising cases of uveitis and related diseases coupled with well-established healthcare infrastructure and rising healthcare expenditure across the region. For instance, according to the Canadian Institute for Health Information (CIHI), total health spending in Canada is expected to reach a new level in 2021, at more than $308 billion, or $8,019 per Canadian. It is anticipated that health expenditure will represent 12.7% of Canada’s gross domestic product (GDP) in 2021, following a high of 13.7% in 2020.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The uveitis treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|1.4.||Currency used in Report|
|2.1.||Research Process of the Uveitis Treatment Market|
|2.2.||Research Methodology of the Uveitis Treatment Market|
|2.5.||Main Objective of the Uveitis Treatment Market study|
|5||UVEITIS TREATMENT MARKET COVID-19 IMPACT|
|6||UVEITIS TREATMENT MARKET REVENUE, 2019-2027F|
|7.3.||Immunotherapy & Targeted Therapies|
|9.2.||Drug Stores & Retail Pharmacies|
|10.1.3.||Rest of America|
|10.2.6.||Rest of Europe|
|10.3.4.||Rest of Asia-Pacific|
|10.4.||Rest of the World|
|12||UVEITIS TREATMENT MARKET OPPORTUNITIES|
|13||UVEITIS TREATMENT MARKET TRENDS|
|14||LEGAL & REGULATORY FRAMEWORK|
|15.1.||Demand Side Analysis|
|15.2.||Supply Side Analysis|
|16||VALUE CHAIN ANALYSIS|
|17.1.1.||Porter’s Five Forces Analysis|
|18.2.||Alimera Sciences, Inc.|
|18.5.||Bausch Health Companies Inc.|
|18.6.||Clearside Biomedical Inc.|
|18.7.||EyePoint Pharmaceuticals Inc.|
|18.10.||Santen Pharmaceutical Co. Ltd.|
Research Methodology for the Uveitis Treatment Market Analysis (2021-2027)
Analyzing the historical market, estimating the current market, and forecasting the future market of the uveitis treatment market were the three major steps undertaken to create and analyze the adoption of the uveitis treatment market in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the uveitis treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the uveitis treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the uveitis treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug class, disease type, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the uveitis treatment market. Further, we conducted factor analysis using dependent and independent variables such as various products, and end-user of the uveitis treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the uveitis treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the uveitis treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast about 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the uveitis treatment market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the uveitis treatment market in terms of solutions offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the uveitis treatment market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of drug class, disease type, and distribution channel in the uveitis treatment market.
The main objective of the uveitis treatment market Study
The current & future market trends of the uveitis treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the uveitis treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of drug class, disease type, and distribution channel.
- Define and analysis of the regulatory framework for the uveitis treatment market industry.
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the uveitis treatment market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the world.
- Company profiles of the uveitis treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry